Abstract:Introduction: Diffusion weighted magnetic resonance spectroscopy (DW-MRS) is useful for evaluation of the intracellular environment [1]. Previous studies showed that the most abundant metabolites that are detected by H-MRS are primarily located in the intracellular compartment of the brain and therefore DW-MRS offers excellent tools to specifically measure the intracellular response to cerebral injury [2]. The pathological changes in cells of glioma and metastatic tumor, the most common types of tumor in human brain, are related to the diagnosis and treatment of cerebral tumors. In this study, the apparent diffusion coefficients of brain metabolites were measured by DW-MRS on a clinical MR scanner for detecting pathological changes in cases of glioma and metastatic tumor in human brain. Methods: Ten glioma patients (6 males and 4 females, mean age 46±15.9 years, range 11-62 years) and six metastatic tumor patients (2 males and 4 females, mean age 70±7.6 years, range 65-84 years) were recruited for this study. Twelve age and sexual-matched health controls (4 males and 8 females, mean age 67±8.4 years, range 60-78 years) were selected for metastatic tumor patients. All the controls were free from neurological or psychiatric disease and their brain MRI scans were normal. All subjects had given their permission to be part of the study which was proved by the Investigational Review Board at our hospital. The DW-MRS sequence based on point resolved spectroscopy (PRESS) sequence technique was implemented for this study. The equipment used for the MR examinations was a 3.0T clinical wholebody system (Signa EXCITE HD; General Electric, Milwaukee, WI) with gradients with a maximum amplitude 40 mT/m and a maximum slew rate 150 mT/m/ms. Parameters for the DW-MRS sequence were as follows: TR 2000 ms, TE 144 ms, voxel size 2×2×2 cm (8 mL), spectral width 5000 HZ, and data points 4096. Data were acquired at only two different b-factor values: 45 and 1050 s/mm. The region of interests of DW-MRS were located in 1) the lesion area of glioma patients and its opposite un-affected areas; 2) the lesion area of metastatic tumor patients and 3) the left frontal cortex of health controls (Fig. 1). Post-spectral processing was carried out by SAGE software (GE Medical Systems). Pure water subtraction was used to reduce residual water from each suppressed frame. Phase corrections were performed before the summation of FIDs. Since the integral peak area was more sensitive to the random noise [4], peak height was used to determine the signal intensity of metabolites in this study. The apparent diffusion coefficients (ADCs) value was estimated by the following equation: ( ) ( ) ( ) 2 1 2 1 ADC=-ln S b S b b -b ⎡ ⎤ ⎣ ⎦ Where S (b1), and S (b2) are the signal intensities for the two b-values, b1 and b2.

Water exchange detected by shutter speed dynamic contrast enhanced-MRI help distinguish solitary brain metastasis from glioblastoma

Combining Amide Proton Transfer-Weighted and Arterial Spin Labeling Imaging to Differentiate Solitary Brain Metastases from Glioblastomas

Discrimination Between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.

Transmembrane Water-Efflux Rate Measured by Magnetic Resonance Imaging As a Biomarker of the Expression of Aquaporin-4 in Gliomas.

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging

Consideration of transmembrane water exchange in pharmacokinetic model significantly improves the accuracy of DCE-MRI in estimating cellular density: A pilot study in glioblastoma multiforme

Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Glioblastoma, Primary Central Nervous System Lymphoma and Brain Metastatic Tumor.

Quantitative Analysis of Mean Apparent Propagator-Magnetic Resonance Imaging for Distinguishing Glioblastoma from Solitary Brain Metastasis

Utilizing Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Analyze Interstitial Fluid Flow and Transport in Glioblastoma and the Surrounding Parenchyma in Human Patients

Quantitative Analysis of Permeability for Glioma Grading Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

A Histopathologic Correlation Study Evaluating Glymphatic Function in Brain Tumors by Multi-Parametric MRI

Correlative assessment of perfusion-related parameters of intravoxel incoherent motion with dynamic contrast ;enhancement in MR imaging of gliomas

Assessing the Microvascular Permeability of Brain Glioma by DCE-MRI

Multiparametric analysis from dynamic susceptibility contrast‐enhanced perfusion MRI to evaluate malignant brain tumors

Quantitative diffusion weighted magnetic resonance spectroscopy of glioma and metastatic tumor in human brain in vivo

Meta-analysis of Peritumoural Rcbv Values Derived from Dynamic Susceptibility Contrast Imaging in Differentiating High-Grade Gliomas from Intracranial Metastases.

Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma

Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma

Nimg-88. Evaluation Of Diffusion And Perfusion Mri Features For Differentiating Recurrent Brain Metastases And Radiation Necrosis

Differentiation Between Brain Glioblastoma Multiforme and Solitary Metastasis: Qualitative and Quantitative Analysis Based on Routine MR Imaging

Differentiation of glioma and solitary brain metastasis: a multi-parameter magnetic resonance imaging study using histogram analysis